feed,title,long_url,short_url
Benzinga,Acer Therapeutics' Stock Down As FDA Rejects Inborn Metabolism Disorder (UCD) Candidate,https://benzinga.com/general/biotech/22/06/27799139/acer-therapeutics-stock-down-as-fda-rejects-inborn-metabolism-disorder-ucd-candidate,https://bit.ly/3QETOvK
Benzinga,Carparts.Com Enters $75M Credit Facility Agreement,https://benzinga.com/news/22/06/27798083/carparts-com-enters-into-75-million-credit-facility-agreement,https://bit.ly/3zPjQqb
